in past times number of years, the UK has witnessed a revolution in health care pounds‑reduction treatment plans — within the introduction of semaglutide (Wegovy®) for the developing popularity of tirzepatide (Mounjaro®). Now, A further name is drawing consideration in equally clinical and public